Enhance Speed, Purity & Scalability of Your Process Development & Manufacturing to Improve Functionality, Efficacy & Approval Rate of mRNA Drugs Across All Disease Indication
Accelerate Next Generation RNAs into Safe & Effective Clinical Candidates with Therapeutic Potentials Across All Diseases by Overcoming Quality, Stability, & Large-Scale Manufacturi
As device developers of all sizes grapple with the updated transition timeline for EU MDR compliance and the recent EU AI Act approval falls short of expectations, the question looms: how can regul
Following Merck announcing their goal to phase out animal use in their work, Astellas and MIMETAS expanding their partnership in immunotherapeutic development, and the domino effects across the fie